{
  "docId": "019de072-122c-721c-8b62-3522a74ffc66",
  "docSlug": "bcca0cb7dade19d9f637477238714c68",
  "documentTitle": "Aeglea BioTherapeutics | Investor Presentation Deck | 33 slides",
  "authorId": "aeglea-biotherapeutics",
  "authorName": "Aeglea BioTherapeutics",
  "documentKindSlug": "conference-presentation",
  "documentKindLabel": "Conference presentation",
  "sourceTypeSlug": "investor_relations",
  "sourceTypeLabel": "Investor relations",
  "presentationDate": "2022-02-01 00:00:00",
  "orientation": "landscape",
  "aspectRatio": 1.7777778,
  "pageNumber": 26,
  "pageCount": 33,
  "prevPage": 25,
  "nextPage": 27,
  "slideType": "key_takeaways",
  "function": "analyze_data",
  "density": "dense",
  "nDataPoints": 8,
  "notes": "The slide highlights the efficacy of pegzilarginase in a clinical setting.",
  "elementsJson": null,
  "metadataConfidence": 1,
  "imagePath": null,
  "slideHref": "/slides/019de072-122c-721c-8b62-3522a74ffc66/26",
  "deckHref": "/decks/019de072-122c-721c-8b62-3522a74ffc66",
  "deckJsonHref": "/decks/019de072-122c-721c-8b62-3522a74ffc66.json",
  "deckAnchorHref": "/decks/019de072-122c-721c-8b62-3522a74ffc66#slide-26",
  "components": [
    {
      "bbox": {
        "h": 0.12,
        "w": 0.94,
        "x": 0.03,
        "y": 0.77
      },
      "kind": "callout",
      "text": "Potential Transformative Therapy for a Patient Population with Previously Unachievable Control of Arginine to Normal Levels",
      "attrs": null,
      "subkind": "primary",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "1cb84d34-a879-4a07-baec-d79ac60d297d",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.55,
        "w": 0.45,
        "x": 0.05,
        "y": 0.18
      },
      "kind": "chart",
      "text": "Proportion of Patients Reaching Normal Arginine Levels (40-115 µM)",
      "attrs": null,
      "subkind": "bar-grouped",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "0450a070-fa8c-4d97-8d6b-60b14172e422",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.35,
        "w": 0.4,
        "x": 0.53,
        "y": 0.22
      },
      "kind": "list",
      "text": "90.5% of pegzilarginase treated patients achieved normal plasma arginine levels (p<0.0001)*; No meaningful change in placebo arm; Treatment surpassed clinical guideline goals.",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "9fceaba6-3beb-418c-aae8-b1b452b4c652",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.03,
        "w": 0.5,
        "x": 0.03,
        "y": 0.9
      },
      "kind": "source-note",
      "text": "* Nominal p value, based on arithmetic mean of values from visit and preceding 3 visits",
      "attrs": null,
      "subkind": null,
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "c22ea1f5-d246-4e27-bf5a-129b97ed3647",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.05,
        "w": 0.7,
        "x": 0.03,
        "y": 0.05
      },
      "kind": "title",
      "text": "Normalization of Plasma Arginine Levels in ARG1-D Patients",
      "attrs": null,
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "9448c4f6-10db-4051-a692-63c1b3b1afbc",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [
    {
      "name": "2x2 matrix",
      "slug": "matrix-2x2",
      "agent": null,
      "layer": "slide",
      "matchId": "26b86092-f20d-4adc-8960-aaf7155d2f63",
      "evidence": "chart/bar-grouped: Proportion of Patients Reaching Normal Arginine Levels (40-115 µM) could be part of a 2x2 matrix",
      "confidence": 0.5
    }
  ],
  "frameworks": [],
  "arcBeats": [],
  "loops": [
    {
      "to": 26,
      "from": 21,
      "name": "Jobs To Be Done",
      "slug": "53-jobs-to-be-done",
      "bestFor": "Product innovation, market entry, competitive positioning",
      "matchId": "9cc0cacb-1c5c-40f5-a519-d219894ab0a2",
      "evidence": "The deck provides clinical data supporting the effectiveness of Pegzilarginase",
      "position": 1,
      "objective": "Show the potential of Pegzilarginase to improve patient outcomes",
      "structure": "The Customer's Job -> Current Solutions (Hired/Fired) -> Unmet Needs -> Our Solution Fit",
      "confidence": 0.7,
      "description": "Reframe the problem around what the customer is trying to accomplish, not what they're buying"
    }
  ],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}